Search

Author/Creator Mangsbo, Sara M

2. Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials. Issue 5 (25th May 2022)

Authors:
Ellingsen, Espen Basmo; Aamdal, Elin; Guren, Tormod; Lilleby, Wolfgang; Brunsvig, Paal F; Mangsbo, Sara M; Aamdal, Steinar; Hovig, Eivind; Mensali, Nadia; Gaudernack, Gustav; Inderberg, Else Marit
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 5(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice. (6th November 2014)

Authors:
Mangsbo, Sara M; Veitonmäki, Niina; Gustfson, Erika; Smith, Karin Enell; Furebring, Christina; Norlén, Per; Lindstedt, Malin; Tötterman, Thomas H; Ellmark, Peter
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy. (1st January 2020)

Authors:
Georganaki, Maria; Ramachandran, Mohanraj; Tuit, Sander; Núñez, Nicolás Gonzalo; Karampatzakis, Alexandros; Fotaki, Grammatiki; van Hooren, Luuk; Huang, Hua; Lugano, Roberta; Ulas, Thomas; Kaunisto, Aura; Holland, Eric C; Ellmark, Peter; Mangsbo, Sara M; Schultze, Joachim; Essand, Magnus; Tugues,...
Journal:
Oncoimmunology
Issue:
Volume 9:Number 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗